Skip to content
Recall Observatory FDA recall evidence

Drug product

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

D-0265-2023

January 30, 2023

Class III

Product summary

Firm
Akorn, Inc.
Event
Event 91580
Status
Ongoing
Classification
Class III
Quantity
45,117 Bottles
Official record key
drug-enforcement:D-0265-2023

Official wording

Reason: Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

Code information: Lot: 081031A, Exp 2/28/2023

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification